‘The Man Who Hated Women’ Is Mostly About the Women He Hated
By Jennifer Szalai,
New York Times
| 07. 12. 2021
“The Man Who Hated Women,” the arresting title of Amy Sohn’s new book, would have been more fitting if the book were truly about the man who hated women. But Sohn’s narrative is less about Anthony Comstock — the self-styled moral crusader and chief architect of the Comstock Act of 1873, which made it a federal offense to send “obscene, lewd or lascivious” material through the mail — than it is about the targets of his hatred, the women themselves.
Aside from offering a few perfunctory biographical details, Sohn mostly depicts Comstock as a nuisance or a cartoon villain — a pathetically obsessed figure who pops up now and again to make life horrendously difficult for the people he pursued. She earnestly pronounces him “the man who did more to curtail women’s rights than anyone else in American history.” More than anyone? Is she sure about that?
Sohn, the author of several dishy novels and a former columnist about sex and relationships for New York Press and New York magazine, doesn’t try to present Comstock as anything more...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...